BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30779269)

  • 1. Insulin pump therapy, pre-pump hemoglobin A
    Botros S; Islam N; Hursh B
    Pediatr Diabetes; 2019 Jun; 20(4):427-433. PubMed ID: 30779269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of insulin pump therapy in children at diagnosis of type 1 diabetes resulted in improved long-term glycemic control.
    Lang EG; King BR; Miller MN; Dunn SV; Price DA; Foskett DC
    Pediatr Diabetes; 2017 Feb; 18(1):26-32. PubMed ID: 26782779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 4. Real-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes.
    Burckhardt MA; Smith GJ; Cooper MN; Jones TW; Davis EA
    Pediatr Diabetes; 2018 Dec; 19(8):1459-1466. PubMed ID: 30129154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of baseline hemoglobin A1c levels prior to initiation of pump therapy on long-term metabolic control.
    Pinhas-Hamiel O; Tzadok M; Hirsh G; Boyko V; Graph-Barel C; Lerner-Geva L; Reichman B
    Diabetes Technol Ther; 2010 Jul; 12(7):567-73. PubMed ID: 20597832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in Scotland.
    McKnight JA; Ochs A; Mair C; McKnight O; Wright R; Gibb FW; Cunningham SG; Strachan M; Ritchie S; McGurnaghan SJ; Colhoun HM
    Diabet Med; 2020 Jun; 37(6):1016-1022. PubMed ID: 31872473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries.
    Sherr JL; Hermann JM; Campbell F; Foster NC; Hofer SE; Allgrove J; Maahs DM; Kapellen TM; Holman N; Tamborlane WV; Holl RW; Beck RW; Warner JT;
    Diabetologia; 2016 Jan; 59(1):87-91. PubMed ID: 26546085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.
    Scott ES; McGrath RT; Januszewski AS; Calandro D; Hardikar AA; O'Neal DN; Fulcher G; Jenkins AJ
    BMJ Open; 2019 Dec; 9(12):e033059. PubMed ID: 31888933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.
    Blackman SM; Raghinaru D; Adi S; Simmons JH; Ebner-Lyon L; Chase HP; Tamborlane WV; Schatz DA; Block JM; Litton JC; Raman V; Foster NC; Kollman CR; DuBose SN; Miller KM; Beck RW; DiMeglio LA
    Pediatr Diabetes; 2014 Dec; 15(8):564-72. PubMed ID: 24494980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
    Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
    Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pump-long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden.
    Carlsson BM; Attvall S; Clements M; Gumpeny SR; Pivodic A; Sternemalm L; Lind M
    Diabetes Technol Ther; 2013 Apr; 15(4):302-7. PubMed ID: 23537418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus.
    Korkmaz Ö; Demir G; Çetin H; Mecidov İ; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):147-152. PubMed ID: 29537377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
    Miller KM; Foster NC; Beck RW; Bergenstal RM; DuBose SN; DiMeglio LA; Maahs DM; Tamborlane WV;
    Diabetes Care; 2015 Jun; 38(6):971-8. PubMed ID: 25998289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Real-World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry.
    Brown RE; Vienneau T; Aronson R
    Diabet Med; 2021 Jun; 38(6):e14420. PubMed ID: 33040383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes.
    Mameli C; Scaramuzza AE; Ho J; Cardona-Hernandez R; Suarez-Ortega L; Zuccotti GV
    Acta Diabetol; 2014 Apr; 51(2):205-10. PubMed ID: 23681558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Transatlantic HbA
    Hermann JM; Miller KM; Hofer SE; Clements MA; Karges W; Foster NC; Fröhlich-Reiterer E; Rickels MR; Rosenbauer J; DeSalvo DJ; Holl RW; Maahs DM;
    Diabet Med; 2020 May; 37(5):848-855. PubMed ID: 31557351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control.
    Duca LM; Wang B; Rewers M; Rewers A
    Diabetes Care; 2017 Sep; 40(9):1249-1255. PubMed ID: 28667128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry.
    Danne T; Schwandt A; Biester T; Heidtmann B; Rami-Merhar B; Haberland H; Müther S; Khodaverdi S; Haak T; Holl RW;
    Pediatr Diabetes; 2018 Aug; 19(5):979-984. PubMed ID: 29446511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting poor glycemic control in the first two years of childhood onset type 1 diabetes in a cohort from East London, UK: Analyses using mixed effects fractional polynomial models.
    Mazarello Paes V; Barrett JK; Dunger DB; Gevers EF; Taylor-Robinson DC; Viner RM; Stephenson TJ
    Pediatr Diabetes; 2020 Mar; 21(2):288-299. PubMed ID: 31782879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.